New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
30th November 2022
US - Ohio: State lawmakers are interested in passing medical cannabis reform, as committees in the state House of Representatives debate Senate Bill 261, press reports. SB 261 was passed by the Senate last December and would make major reforms to Ohio's medical cannabis programme by creating a new regulatory agency – the Division of Marijuana Control – increasing the number of medical cannabis dispensaries, and expanding qualifying conditions for doctors to prescribe cannabis for to include those “that the patient’s symptoms may reasonably be expected to be relieved from medical marijuana”. The legislative session ends at the end of December.
16th May 2022
2nd May 2022
27th April 2022
15th February 2022
Ohio: Senate president Matt Huffman has said he will not bring a citizen-initiated bill to legalise recreational cannabis to the Senate floor, local press reports. Organisers of the initiative will need to gather more signatures for the measure to be placed on the ballot in November.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.